ESC Premium Access

Efficacy and safety of alcohol septal ablation in adolescents and young adults with symptomatic hypertrophic obstructive cardiomyopathy

Presentation

About the speaker

Doctor Dennis Lawin

University Hospital OWL of Bielefeld University, Campus Klinikum Bielefeld, Bielefeld (Germany)
0 follower

93 more presentations in this session

Combination of arrhythmogenic right ventricular dysplasia with left ventricular non-compaction as a special form of cardiomyopathy: clinic, diagnostics, genetic, natural course

Speaker: Professor O. Blagova (Moscow, RU)

Thumbnail

Cardiac rupture - the most serious complication of takotsubo syndrome

Speaker: Doctor M. Zalewska-Adamiec (Bialystok, PL)

Thumbnail

Noncompact myocardium with dilated phenotype: differences in comparison with other forms of dilated cardiomyopathy..

Speaker: Professor O. Blagova (Moscow, RU)

Thumbnail

Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA in patients with hypertrophic cardiomyopathy

Speaker: Doctor A. Trongtorsak (Evanston, US)

Thumbnail

The contemporary study of acute myocarditis in south africa - CAMISA

Speaker: Doctor K. Hassan (Cape Town, ZA)

Thumbnail

Access the full session

Myocardial and pericardial disease e-posters

Speakers: Doctor D. Lawin, Professor O. Blagova, Doctor M. Zalewska-Adamiec, Professor O. Blagova, Doctor A. Trongtorsak...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Comparative effectiveness of NOAC vs VKA in patients representing common clinical challenges: results from the GARFIELD-AF registry

27 August 2021

ESC Premium Access

Time at home among nonvalvular atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: an ARISTOPHANES analysis

27 August 2021

ESC Premium Access

Association between renal function and clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry

27 August 2021

This platform is supported by

logo Novo Nordisk